Cannapharmarx (CPMD) has released an update.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
CannaPharmaRx, an emerging power in the cannabis production industry, has successfully completed its initial series of cannabis harvests with products soon to be distributed across Canada and internationally, following independent lab testing. With an anticipated annual production capacity of 6000kg, translating to approximately $18 million in revenue, the company has secured pre-sale agreements for the bulk of its product. Additionally, CannaPharmaRx has scheduled an investor conference call to discuss year-to-date progress and future strategies.
For further insights into CPMD stock, check out TipRanks’ Stock Analysis page.